This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
SPRAVATO® (esketamine)
Medical Information
Concomitant Use of SPRAVATO with COVID-19 Vaccines
Last Updated: 09/15/2026
SUMMARY
- Use with COVID-19 Vaccines
- Currently, there are no published studies on the concomitant use of COVID-19 vaccines and SPRAVATO.
- Clinicians should use clinical judgement based on local/institutional guidelines, standards of care, and individual patient risk/benefit assessment when considering concomitant use of SPRAVATO and COVID-19 vaccines.
- For additional information regarding the use of COVID-19 vaccines, please contact the vaccine manufacturer.
- General Vaccination Information
Literature Search
A literature search of MEDLINE®
09 September 2026.
References
| 1 | Centers for Disease Control and Prevention (CDC). COVID-19 ACIP vaccine recommendations. Centers for Disease Control and Prevention (CDC); 2020. Accessed September 9, 2026. |
Would you like to clear and leave your conversation? Message history will be lost.